Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care

Bone

Volumn 50, Issue 1, 2012, Pages 85-90

  Lapi, F ^a   Simonetti, M ^b   Michieli, R ^c   Pasqua, A ^b   Brandi, M L ^a   Frediani, B ^d   Cricelli, C ^c   Mazzaglia, G ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Health Search   (Italy)

^c Italian College of General Practitioners   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

Incidence rate; Osteoporotic fracture; Primary care; Risk factors

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DATA REPOSITORY; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; GASTROINTESTINAL DISEASE; HEALTH SURVEY; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; OSTEOPOROSIS; PRIMARY MEDICAL CARE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PRIMARY HEALTH CARE; RISK FACTORS; SEX FACTORS;

EID: 80054855038     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.09.048     Document Type: Article

References (38)

1. NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J 2001, 94:569-573.
2. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359:1761-1767.
3. Adami S., Giannini S., Giorgino R., Isaia G.C., Maggi S., Sinigaglia L., et al. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study. Calcif Tissue Int 2004, 74:317-321.
4. Piscitelli P., Gimigliano F., Gatto S., Marinelli A., Gimigliano A., Marinelli P., et al. Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int 2010, 21:1323-1330.
5. Johnell O., Kanis J.A., Oden A., Johansson H., De Laet C., Delmas P., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005, 20:1185-1194.
6. Kanis J.A., Johnell O., Oden A., Johansson H., McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385-397.
7. Wainwright S.A., Marshall L.M., Ensrud K.E., Cauley J.A., Black D.M., Hillier T.A., et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005, 90:2787-2793.
8. Black D.M., Steinbuch M., Palermo L., Dargent-Molina P., Lindsay R., Hoseyni M.S., et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001, 12:519-528.
9. Kanis J.A., Oden A., Johnell O., Johansson H., De Laet C., Brown J., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:1033-1046.
10. Kanis J.A., Johansson H., Oden A., McCloskey E.V. Assessment of fracture risk. Eur J Radiol 2009, 71:392-397.
11. Hippisley-Cox J., Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009, 339:b4229.
12. Lawrenson R., Williams T., Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999, 21:299-304.
13. Filippi A., Bignamini A.A., Sessa E., Samani F., Mazzaglia G. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003, 34:1010-1014.
14. Mazzaglia G., Ambrosioni E., Alacqua M., Filippi A., Sessa E., Immordino V., et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009, 120:1598-1605.
15. Cricelli C., Mazzaglia G., Samani F., Marchi M., Sabatini A., Nardi R., et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003, 25:254-257.
16. Iolascon G., Gimigliano F., Piscitelli P., Guida G. Hip fracture in Italy: analysis of DRG data. Aging Clin Exp Res 2007, 19:2-4.
17. Piscitelli P., Iolascon G., Gimigliano F., Muratore M., Camboa P., Borgia O., et al. Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int 2007, 18:211-219.
18. Pluijm S.M., Koes B., de Laet C., Van Schoor N.M., Kuchuk N.O., Rivadeneira F., et al. A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res 2009, 24:768-774.
19. Piscitelli P., Brandi M.L., Tarantino U., Baggiani A., Distante A., Muratore M., et al. Incidence and socioeconomic burden of hip fractures in Italy: extension study 2003-2005. Reumatismo 2010, 62:113-118.
20. Kanis J.A., Borgstrom F., De Laet C., Johansson H., Johnell O., Jonsson B., et al. Assessment of fracture risk. Osteoporos Int 2005, 16:581-589.
21. Cummings S.R., Nevitt M.C., Browner W.S., Stone K., Fox K.M., Ensrud K.E., et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995, 332:767-773.
22. Cummings S.R. Treatable and untreatable risk factors for hip fracture. Bone 1996, 18:165S-167S.
23. Nakken K.O., Tauboll E. Bone loss associated with use of antiepileptic drugs. Expert Opin Drug Saf 2010, 9:561-571.
24. Lee R.H., Lyles K.W., Colon-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 2010, 8:34-46.
25. Mezuk B., Morden N.E., Ganoczy D., Post E.P., Kilbourne A.M. Anticonvulsant use, bipolar disorder, and risk of fracture among older adults in the Veterans Health Administration. Am J Geriatr Psychiatry 2010, 18:245-255.
26. Huang Z., Himes J.H., McGovern P.G. Nutrition and subsequent hip fracture risk among a national cohort of white women. Am J Epidemiol 1996, 144:124-134.
27. Barrett-Connor E., Nielson C.M., Orwoll E., Bauer D.C., Cauley J.A. Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ 2010, 340:c1069.
28. Cooper C., Cole Z.A., Holroyd C.R., Earl S.C., Harvey N.C., Dennison E.M., et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 2011, 22:1277-1288.
29. Cheng S.Y., Levy A.R., Lefaivre K.A., Guy P., Kuramoto L., Sobolev B. Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int 2011, 2575-2586.
30. White S.C., Atchison K.A., Gornbein J.A., Nattiv A., Paganini-Hill A., Service S.K. Risk factors for fractures in older men and women: The Leisure World Cohort Study. Gend Med 2006, 3:110-123.
31. Maravic M., Le Bihan C., Landais P., Fardellone P. Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Osteoporos Int 2005, 16:1475-1480.
32. Lippuner K., von Overbeck J., Perrelet R., Bosshard H., Jaeger P. Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos Int 1997, 7:414-425.
33. Gallus S., Muttarak R., Martinez-Sanchez J.M., Zuccaro P., Colombo P., La Vecchia C. Smoking prevalence and smoking attributable mortality in Italy, 2010. Prev Med 2011, 52:434-438.
34. Crutzen R., Goritz A.S. Social desirability and self-reported health risk behaviors in web-based research: three longitudinal studies. BMC Public Health 2010, 10:720.
35. Ziere G., Dieleman J.P., van der Cammen T.J., Stricker B.H. Association between SSRI use and fractures and the effect of confounding by indication. Arch Intern Med 2007, 167:2369-2370. (author reply 2370-1).
36. Nilsson O.S., Lindholm T.S., Elmstedt E., Lindback A., Lindholm T.C. Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment. Arch Orthop Trauma Surg 1986, 105:146-149.
37. Kanis J.A., Oden A., Johansson H., Borgstrom F., Strom O., McCloskey E. FRAX and its applications to clinical practice. Bone 2009, 44:734-743.
38. Kanis J.A., McCloskey E.V., Johansson H., Strom O., Borgstrom F., Oden A. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 2008, 19:1395-1408.